EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness

被引:96
作者
Ruether, T. [1 ]
Bobes, J. [2 ]
De Hert, M. [3 ]
Svensson, T. H. [4 ]
Mann, K. [5 ]
Batra, A. [6 ]
Gorwood, P. [7 ]
Moeller, H. J. [1 ]
机构
[1] Univ Munich, Dept Psychiat, D-80336 Munich, Germany
[2] Univ Oviedo, Dept Med, Psychiat Area, Ctr Invest Biomed Red Salud Mental, Oviedo, Asturias, Spain
[3] Katholieke Univ Leuven, Univ Psychiat Ctr, Dept Neurosci, KU Leuven, B-3070 Kortenberg, Belgium
[4] Karolinska Inst, Dept Physiol & Pharmacol, Sect Neuropsychopharmacol, Stockholm, Sweden
[5] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany
[6] Univ Tubingen Hosp, Dept Psychiat & Psychotherapy, Sect Addict Med & Res, Tubingen, Germany
[7] Univ Paris 05, St Anna Hosp, CMME, Paris, France
关键词
Mental disorders; Tobacco use cessation; Smoking; Tobacco dependence; Schizophrenia; Affective disorders; PLACEBO-CONTROLLED TRIAL; NICOTINE REPLACEMENT THERAPY; BUPROPION SUSTAINED-RELEASE; SUBSTANCE-ABUSE TREATMENT; MONOAMINE-OXIDASE-A; CIGARETTE-SMOKING; DOUBLE-BLIND; PHYSICAL HEALTH; FAGERSTROM TEST; CONTINGENCY MANAGEMENT;
D O I
10.1016/j.eurpsy.2013.11.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Tobacco dependence is the most common substance use disorder in adults with mental illness. The prevalence rates for tobacco dependence are two to four times higher in these patients than in the general population. Smoking has a strong, negative influence on the life expectancy and quality of life of mental health patients, and remains the leading preventable cause of death in this group. Despite these statistics, in some countries smokers with mental illness are disadvantaged in receiving intervention and support for their tobacco dependence, which is often overlooked or even tolerated. This statement from the European Psychiatric Association (EPA) systematically reviews the current evidence on tobacco dependence and withdrawal in patients with mental illness and their treatment. It provides seven recommendations for the core components of diagnostics and treatment in this patient group. These recommendations concern: (1) the recording process, (2) the timing of the intervention, (3) counselling specificities, (4) proposed treatments, (5) frequency of contact after stopping, (6) follow-up visits and (7) relapse prevention. They aim to help clinicians improve the care, health and well-being of patients suffering from mental illness. (c) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:65 / 82
页数:18
相关论文
共 291 条
[1]  
Abrams D.B., 2003, TOBACCO DEPENDENCE T
[2]   The construct of internalization: conceptualization, measurement, and prediction of smoking treatment outcome [J].
Acton, GS ;
Kunz, JD ;
Wilson, M ;
Hall, SM .
PSYCHOLOGICAL MEDICINE, 2005, 35 (03) :395-408
[3]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[4]   CONTINGENCY MANAGEMENT PROMOTES SMOKING REDUCTIONS IN RESIDENTIAL SUBSTANCE ABUSE PATIENTS [J].
Alessi, Sheila M. ;
Petry, Nancy M. ;
Urso, Julie .
JOURNAL OF APPLIED BEHAVIOR ANALYSIS, 2008, 41 (04) :617-622
[5]   Effect of Nicotine Replacement Therapy on Agitation in Smokers With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study [J].
Allen, Michael H. ;
Debanne, Martin ;
Lazignac, Coralie ;
Adam, Eric ;
Dickinson, L. Miriam ;
Damsa, Cristian .
AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (04) :395-399
[6]   A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation [J].
Alpert, Hillel R. ;
Connolly, Gregory N. ;
Biener, Lois .
TOBACCO CONTROL, 2013, 22 (01) :32-37
[7]  
American Psychiatric Association, 2006, PRACTICE GUIDELINE T, V2nd, P291
[8]   DEPRESSION AND THE DYNAMICS OF SMOKING - A NATIONAL PERSPECTIVE [J].
ANDA, RF ;
WILLIAMSON, DF ;
ESCOBEDO, LG ;
MAST, EE ;
GIOVINO, GA ;
REMINGTON, PL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12) :1541-1545
[9]  
Andreas S, 2008, Pneumologie, V62, P255, DOI 10.1055/s-2008-1038148
[10]   Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test [J].
Andreasen, Jesper T. ;
Nielsen, Elsebet O. ;
Christensen, Jeppe K. ;
Olsen, Gunnar M. ;
Peters, Dan ;
Mirza, Naheed R. ;
Redrobe, John P. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (10) :1347-1356